Search Within

Vladimir Aleksandrov Markov

Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Sloan Kettering Institute Postdocs (5)
  4. Solid Tumor Oncology Division (5)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (3)

More Groups

People
  1. Elisa De Stanchina (5)
  2. Charles Rudin (3)
  3. Alvaro Quintanal Villalonga (2)
  4. Arielle Elkrief (2)
  5. Gregory Riely (2)
  6. Igor Odintsov (2)

More People

Years
  1. 2024 (4)
  2. 2023 (1)
Publications
  1. Journal of Thoracic Oncology (2)
  2. Nature Communications (2)
  3. JCO Precision Oncology (1)
Publishers
  1. Elsevier Inc. (2)
  2. Nature Publishing Group (2)
  3. American Society of Clinical Oncology (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Journal Article

    Roychowdhury, T.; McNutt, S. W.; Pasala, C.; Nguyen, H. T.; Thornton, D. T.; Sharma, S.; Botticelli, L.; Digwal, C. S.; Joshi, S.; Yang, N.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combined inhibition of KRAS(G12C) and mTORC1 kinase is synergistic in non-small cell lung cancer
    Journal Article

    Kitai, H.; Choi, P. H.; Yang, Y. C.; Boyer, J. A.; Whaley, A.; Pancholi, P.; Thant, C.; Reiter, J.; Chen, K.; Markov, V.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save